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Abstract
 
Low molecular weight fragmentation products of the polysaccharide of Hyaluronic acid (sHA)
produced during inflammation have been shown to be potent activators of immunocompetent
cells such as dendritic cells (DCs) and macrophages. Here we report that sHA induces matura-
tion of DCs via the Toll-like receptor (TLR)-4, a receptor complex associated with innate im-
munity and host defense against bacterial infection. Bone marrow–derived DCs from C3H/
HeJ and C57BL/10ScCr mice carrying mutant TLR-4 alleles were nonresponsive to sHA-
induced phenotypic and functional maturation. Conversely, DCs from TLR-2–deficient mice
were still susceptible to sHA. In accordance, addition of an anti–TLR-4 mAb to human mono-
cyte–derived DCs blocked sHA-induced tumor necrosis factor 
 
 
 
 production. Western blot
analysis revealed that sHA treatment resulted in distinct phosphorylation of p38/p42/44 MAP-
kinases and nuclear translocation of nuclear factor (NF)-
 
 
 
B, all components of the TLR-4 sig-
naling pathway. Blockade of this pathway by specific inhibitors completely abrogated the sHA-
induced DC maturation. Finally, intravenous injection of sHA-induced DC emigration from
the skin and their phenotypic and functional maturation in the spleen, again depending on the
expression of TLR-4. In conclusion, this is the first report that polysaccharide degradation
products of the extracellular matrix produced during inflammation might serve as an endoge-
nous ligand for the TLR-4 complex on DCs.
 
Key words: extracellular matrix • glycosaminoglycans • dendritic cells • Hyaluronan • 
toll-like receptors
 
Introduction
 
Hyaluronic acid (HA)
 
*
 
, one of the major glycosaminogly-
cans of the extracellular matrix, has been shown to undergo
rapid degradation at sites of inflammation (1, 2). In its na-
tive state, HA is a high-molecular mass (up to 10
 
6
 
 Da) non-
sulfated, linear polysaccharide consisting of repeating units
of (
 
 
 
,1–4)-d-glucuronic acid-(
 
 
 
,1–3)-
 
N
 
-acetyl-D-glucos-
amine (3). Recently, low-molecular weight degradation
products of HA have been found to elicit various proin-
flammatory responses such as the activation of murine alve-
olar macrophages as well as the stimulation and invasion of
macrophages into affected joints in rheumatoid arthritis (4,
5). We have recently shown that low-molecular weight
oligosaccharides of HA (sHA) induced complete and irre-
versible phenotypic and functional maturation of human
DCs, in contrast to high-molecular weight HA (HMW-
HA) which had no such effect (5). These effects of sHA
were independent of the major HMW-HA receptors
RHAMM and CD44 and were highly specific for sHA
since other glycosaminoglycans of disaccharide structure
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similar to HA, such as chondroitin sulfate, heparan sulfate,
or their fragmentation products were not effective (5, 6).
Furthermore, in contrast to HMW-HA, sHA has also been
reported to induce specific intracellular signaling pathways
in immunocompetent cells and endothelial cells (7). These
include activation of mitogen-activated protein kinases
(MAPKs) in vascular endothelium and the translocation of
NF-
 
 
 
B to the nucleus in murine alveolar macrophages, in
murine kidney tubular epithelium and in rat hepatic cells
(4, 8–10).
Recently, the so-called Toll-like receptors (TLRs), a
new group of receptors belonging to the IL-1 receptor
family have been described (11–14). TLRs were initially
discovered in 
 
Drosophila
 
 and are conserved amongst various
species. They are involved in the activation of immuno-
competent cells such as macrophages and DCs and thus
participate in the innate defense against bacterial infection
(11, 12, 14, 15). Several TLRs have been identified in
blood macrophages and cells of the myelomonocytic lin-
eage, but TLR-2 and TLR-4 appear to be particularly im-
portant for DC activation (13, 14). Unlike other receptors
involved in DC activation such as CD14 (16), TLRs have a
transmembrane domain (12) that associates with the intra-
cellular adaptor protein MyD88 (17, 18) which mediates
TLR-induced signal transduction through its interaction
with the serine kinase IRAK (18). LPS-mediated activation
of the TLR-4 complex was found to induce specific signal-
ing pathways involving the phosphorylation of p38, p42/
p44 MAPKs, c-Jun NH
 
2
 
-terminal kinase, and led to libera-
tion of NF-
 
 
 
B/Rel family members into the nucleus (13,
19). However, activation of the TLR-4 receptor complex
is not limited to LPS, and other proinflammatory stimuli
such as Taxol and Heat-Shock Protein 60 (HSP-60) have
been described as alternative ligands (20, 21).
These recent findings prompted us to determine whether
TLR-4 receptors are involved in sHA-mediated DC matu-
ration, and whether this might be associated with the acti-
vation of distinct intracellular signaling pathways. In this
paper we show that TLR-4 plays a critical role during acti-
vation of human and murine DCs by sHA in vivo and in
vitro, and that sHA stimulation induces the TLR-4 signal
transduction pathway involving p38/p42–44 MAPKs and
NF-
 
 
 
B translocation.
 
Materials and Methods
 
Experimental Animals.
 
6–8-wk-old female C57BL/10 and
C57BL/10ScCr or C3H/HeN or C3H/HeJ mice (12) as well as
TLR-2–deficient C57BL/6 and C57BL/6 wild-type mice (14)
were maintained in the specific pathogen-free facility of the Max-
Planck Institute for Immunobiology in Freiburg, Germany.
 
Materials.
 
The MAPK inhibitors SB203580, PD 98059,
Wortmannin, Herbimycin A, and CAPE were purchased from
Alexis Corporation. LPS from 
 
Salmonella minnesota
 
 Re-595, 
 
Sal-
monella abortus equi
 
, or crude cell wall extracts were prepared as
described previously (22).
Polymyxin B, a cationic antibiotic that displaces Ca
 
2
 
 
 
 from an-
ionic phospholipids, was obtained from Calbiochem. The mono-
 
clonal anti–human TLR-4 antibody was used for FACS
 
®
 
 analysis
and blocking studies in concentrations described previously (23).
 
Preparation of the HA Fragments.
 
HMW-HA (HEALON™)
for clinical application with an endotoxin content 
 
 
 
0.1 ng/mg
was provided by Amersham Pharmacia Biotech. Small HA-frag-
mentation products (sHA) were generated by enzymatic digestion
as described previously (5). After digestion and separation, a stock
solution of 1 mg/ml sHA was prepared, which contained 
 
 
 
0.1
ng/ml LPS as determined by Limulus amebocyte lysate (LAL) as-
says. For experimental use this was diluted to a final concentra-
tion of 20–50 
 
 
 
g/ml, with a maximal estimated Endotoxin con-
tent of 0.005 ng/ml for a 50 
 
 
 
g/ml concentration.
 
Preparation of Human DCs.
 
Buffy coats from healthy blood
donors were obtained from the Department of Transfusion Med-
icine, Freiburg University Medical Center, Freiburg, Germany.
White blood cells were separated on an endotoxin-free Ficoll-
paque plus™ gradient (Amersham Pharmacia Biotech) and incu-
bated with a nonactivating, nonblocking anti–human-CD14
mAb (Clone 26IC; American Type Culture Collection) for 45
min on ice. The cells were washed several times in PBS before
incubation with the appropriate secondary anti–mouse MACS
 
®
 
-
Beads (Miltenyi Biotech). CD14
 
 
 
 cells were purified by magnetic
cell sorting using a VS-column MACS
 
®
 
 system™ (Miltenyi Bio-
tech). Purity of separated monocytes was 
 
 
 
90% as determined by
flow cytometry. Monocytes (5 
 
 
 
 10
 
6
 
 cells per well) were seeded
into 6-well flat-bottomed plates (Costar) and cultured at 37
 
 
 
C,
5% CO
 
2
 
 for 4 d in RPMI 1640 (GIBCO BRL) supplemented
with 5% endotoxin-free human serum albumin (Bayer Diagnos-
tics), GCP/GMP quality 1,000 U/ml GM-CSF (Leukomax™;
Novartis), and 100 U/ml IL-4 (provided by Schering-Plough).
The CD14 mAb disappeared completely from the cell surface of
monocytes on day 3 of culture, as determined by flow cytometry.
 
Generation of Murine Bone Marrow–derived DCs.
 
DCs were
generated following the method of Inaba et al. (24), with minor
alterations. BM was harvested from the tibia and femur of
C57BL/6 mice (
 
n 
 
  
 
4). The cells were resuspended at 10
 
6
 
 cells
per milliliter cRPMI 1640 (GIBCO BRL) with 40 ng/ml GM-
CSF and 100 ng/ml IL-4 (both PromoCell). Cells were fed on
days 3 and 5 of culture, by replacing half the medium in each well
with fresh cRPMI containing GM-CSF and IL-4. On day three,
nonadherent cells were aspirated off, after gentle swirling of the
plate. On day 6, loosely adherent cells including DCs were har-
vested by gentle pipetting. DCs were washed once and resus-
pended at 
 
 
 
5 
 
 
 
 10
 
5
 
 cells per milliliter in cRPMI. Aliquots of the
cell suspension (8 ml) were underlayed with 2 ml 14.5% metriza-
mide (Boehringer Ingelheim) in a 14-ml conical bottomed tube
(Becton Dickinson) and centrifuged at room temperature (22
 
 
 
C)
for 20 min at 600
 
 
 
 
 
g
 
. The low buoyant density cells were col-
lected, washed twice, and resuspended for use. Purity of Iab-pos-
itive cells was 
 
 
 
70% as determined by flow cytometry
 
TNF-
 
 
 
 ELISA.
 
Supernatants from unstimulated, LPS- or
sHA-stimulated DCs were collected at the indicated time points
to determine the content of TNF-
 
 
 
. The ELISA assays were de-
veloped according to the manufacturer’s instructions (Becton
Dickinson) and measured at an extinction of 630 nm in a 
 
M
 
r
 
 5000
ELISA reader and analyzed using Bio-Linx™ Software (both Dy-
natech).
 
Lymphocyte Preparation/T Cell Proliferation Assay.
 
Spleen lym-
phocytes were isolated by mincing the organ with the back of a
10-ml syringe in a dish before passing it through a 60-
 
 
 
m nylon
mesh cell strainer. Red blood cells were removed by addition of
lysing solution (0.15 M NH
 
4
 
Cl, 1 mM KHCO
 
3
 
, 0.1 mM Na
 
2
 
-
EDTA adjusted to a pH of 7.2) for 5 min. Remaining APCs 
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were removed by negative selection with a magnetic bead–
labeled mAb against CD4
 
 
 
 for 45 min at 4
 
 
 
C followed by mag-
netic cell sorting (MACS
 
®
 
; Miltenyi Biotech). Flow cytometry
showed purity of the CD4
 
 
 
 cells to be 
 
 
 
85% and IA-expressing
cells to be 
 
 
 
1%. The cells did not respond to PHA stimulation.
The magnetic beads were removed from the CD4
 
 
 
 
 
cells by incu-
bation with CD4-detecha-beads and magnetic cell sorting
(MACS
 
®
 
; Miltenyi Biotech). Purified CD4
 
 
 
 cells in cRPMI
1640 were plated at 10
 
5
 
 cells per well in round-bottomed 96-
well plates (Costar) together with 5 
 
 
 
 10
 
3 
 
allogeneic DCs per
well and incubated at 37
 
 
 
C, 5% CO
 
2
 
. On day 4, 1 
 
 
 
Ci/well
 
3
 
[H]thymidine (Amersham Pharmacia Biotech) was added for the
final 18 h of culture. Finally, the plates were harvested onto 96-
well glass-fiber filter plates and the radioactivity was determined
by liquid scintillation spectroscopy using a TopCount 
 
 
 
-counter
(all Canberra Packard).
 
Immunostaining and Flow Cytometry.
 
DCs were incubated
with primary mAb for 30 min at 4
 
 
 
C, then washed, and stained
with the appropriate FITC-labeled secondary mAb. To deter-
mine cell viability and to exclude dead cells, 1 
 
 
 
g/ml propidium
iodide (Sigma-Aldrich) was added. Samples of 5 
 
 
 
 10
 
4
 
 cells were
analyzed using a FACScan™ together with CELLQuest™ re-
search software (both Becton Dickinson).
 
Determination of Phosphorylated Forms of p42/44 and p38-MAPK
by Western Blot Analysis.
 
Activated forms of p42/44 MAPK
(ERK1/2) and p38 MAPK were detected by Western blot analy-
sis using antibodies to the phosphorylated forms of these kinases.
Extracts from untreated cells and from cells cultured with sHA or
LPS were made by sonication in ice-cold RIPA buffer (150 mM
NaCl, 0.1 mM Tris-HCl, pH 7.2, 1% Triton X-100, 1% sodium
deoxycholate, 0.1% SDS, 5 mM EDTA) containing a mixture of
protease inhibitors and the phosphatase inhibitors sodium ortho-
vanadate (1 mM) and glycerophosphate (50 mM). For Western
blot analysis, 100 
 
 
 
g cell extract proteins were electrophoresed in
a SDS/12% polyacrylamide gel and electroblotted onto a nitro-
cellulose filter. Blots were blocked for 1 h at room temperature in
PBS containing 0.2% Tween 20 and 5% low fat milk. They were
then incubated overnight at 4
 
 
 
C with rabbit polyclonal antibodies
recognizing either the unphosphorylated forms of p42/44 MAPK
or p38 MAPK, or the double phosphorylated (Thr-202/Tyr-204)
p42/44 MAPK or (Thr-180/Tyr-182) p38 MAPK (New En-
gland Biolabs). Blots were then washed five times and incubated
for 1 h at room temperature with horseradish peroxidase-conju-
gated goat anti–rabbit IgG (Santa Cruz Biotechnology, Inc.). Af-
ter further washing, the blots were developed with the Enhanced
Chemiluminescence detection (ECD) kit (Amersham Pharmacia
Biotech). Bands of p42/44 MAPK or p38 MAPK were visualized
after exposing the blots to a Kodak RX film.
 
Preparation of Nuclear Extracts and EMSA.
 
NF-
 
 
 
B oligonucle-
otide (Promega) was labeled using 
 
 
 
-
 
32
 
[P]ATP (3,000 Ci/mmol;
Amersham) and T4 polynucleotide kinase (Promega). Nuclear
extracts from DC were prepared as described previously (25). In
brief, total cell extracts were prepared using a high-salt detergent
buffer (20 mM Hepes, pH 7.9, Totex; 350 mM NaCl; 20% [wt/
vol] glycerol; 1% [wt/vol] NP-40; 1 mM MgCl
 
2
 
; 0.5 mM
EDTA; 0.1 mM EGTA; 0.5 mM DTT; 0.1% PMSF; and 1%
aprotinin). Cells were harvested by centrifugation, washed once
in ice-cold PBS (Sigma-Aldrich) and resuspended in four cell vol-
umes of Totex buffer. After 30 min on ice, the lysates were cen-
trifuged for 5 min at 13,000
 
 
 
 
 
g
 
 at 4
 
 
 
C. The protein content of
the supernatant was determined and equal amounts of protein
(10–20 
 
 
 
g) were added to a reaction mixture containing 20 
 
 
 
g
BSA (Sigma-Aldrich), 2 
 
 
 
g of poly (dI dC) (Boehringer Mann-
 
heim), 2 
 
 
 
l of buffer D
 
 
 
 (20% mM Hepes, pH 7.9, 20% glycerin,
100 mM KCl, 0.5 mM EDTA, 0.25% NP-40, 2 mM DTT, and
0.1% PMSF), 4 
 
 
 
l of buffer F (20% Ficoll 400, 100 mM Hepes,
300 mM KCl, 10 mM DTT, and 0.1% PMSF), and 100,000 cpm
(Cerenkov) of a 
 
32
 
[P]-labeled oligonucleotide in a final volume of
20 
 
 
 
l. Samples were incubated at room temperature for 25 min.
NF-
 
 
 
B oligonucleotide (Promega) was labeled using 
 
 
 
-
 
32
 
[P]ATP
(3,000 Ci/mmol; Amersham Pharmacia Biotech) and T4 polynu-
cleotide kinase (Promega). The samples were separated on a 6%
acrylamide TBE gel, which was dried and subjected to autora-
diography.
 
Assessment of TLR-4 and TLR-2 mRNA Expression.
 
RT-PCR
analysis of human TLR-4 was assessed as described previously
(26). Total RNA was isolated from monocyte-derived DCs using
the Pharmacia Quick prep kit (Amersham Pharmacia Biotech)
according to the manufacturer’s instructions. cDNA was synthe-
sized from 5 
 
 
 
g of total RNA using Superscript II reverse tran-
scriptase (GIBCO BRL). The product was subjected to 30 cycles
of PCR amplification at 94
 
 
 
C/1 min, 72
 
 
 
C/2 min, 55
 
 C/3 min
using Taq-DNA-polymerase (GIBCO BRL). The forward and
reverse PCR primers used for human TLR-4 were 5 -TGGA-
TACGTTTCCTTATAAG-3  and 5 -GAAATGGAGGCACC-
CCTTC-3 , giving an amplification product of 506 bp. Primers
for TLR-2 were used as described previously (27): 5 -TAT-
CGTCTTCCTGGTTCAAGCC-3  and 5 -AACAGAGCACA-
GATGCCAGAC-3 , resulting in an amplification product of
1,452 bp. Aliquots of the PCR reaction products (25  l) were
analyzed by electrophoresis on 1% agarose gels.
Skin Organ Cultures. Full thickness skin containing epidermis
plus papillary dermis from C57BL/10ScSn wild-type (TLR / )
and TLR-4 /  C57BL/10Cr mice (three mice per group) was
obtained by mechanical disaggregation of the outer epidermal
sheet from the cartilage of the ears. Ear sheets were floated on
supplemented RPMI 1640 in 6-well plates (Greiner) with or
without addition of 30  g/ml sHA or 100 ng/ml LPS. After
24 h, cells that had migrated into the culture medium were col-
lected from each group and double stained with FITC-conju-
gated CD11c and IaB PE-conjugated mAbs. FACS® analysis was
performed as described above. All cells obtained from one well
(5–6   105 cells) were analyzed and large, highly CD11c and IaB-
positive cells were considered as DCs and the percentage was cal-
culated using the CELLQuest™ software (Becton Dickinson).
Intravenous Injection Experiments. C57BL/6ScSn wild-type or
SnCr TLR-4–deficient mice (three mice per group) were in-
jected into the tail vein with 100  g sHA, 10  g LPS, or 100  l
PBS. After 12 h the mice were killed and the spleen DCs were
purified by passing the spleens through a 60- m nylon mesh cell
strainer. Red blood cells were removed as described above. DCs
were prepared by negative selection with magnetic bead-labeled
mAbs against CD3 (pan T cell) and B220 (pan B cell) for 45 min
at 4 C followed by magnetic cell sorting (MACS®; Miltenyi Bio-
tech). 5   103 DCs were incubated for 5 d in an allogenic T cell
proliferation assay with 105 BALB/c T cells as described above.
Results
Terminal Maturation of both Human and Murine DCs Is In-
duced by sHA. We and others have proposed that during
inflammation high molecular weight hyaluronate is de-
graded by enzymes released from activated fibroblasts.
These degradation products can deliver activation signals to
DC and macrophages (2, 5). sHA fractions containing sugar102 Oligosaccharides of Hyaluronan Activate Dendritic Cells via TLR-4
units of 4–16 oligosaccharide size stimulated phenotypic and
functional maturation of human monocyte-derived DCs, in
contrast to HMW-HA (5). Maturation included upregula-
tion of MHC class II and costimulatory B7-molecules, an
enhanced allostimulatory capacity and an increased produc-
tion of proinflammatory cytokines. This was independent of
LPS-contamination, since preincubation with polymyxin B
had no effect (5). Furthermore, LAL assays revealed that the
maximal endotoxin content in our sHA preparations was
 0.1 ng/ml, a concentration which is unable to induce
functional or phenotypic DC maturation (reference 5, and
data not shown). To facilitate further analysis of sHA-medi-
ated DC maturation using distinct mouse strains, we set out
to determine whether sHA also effectively activates murine
DCs. Immature bone marrow–derived DCs from C57/BL-6
mice were coincubated for 48 h with either sHA, HMW-
HA or LPS, or were left untreated. Only sHA, but not
HMW-HA, induced maturation of murine DCs as shown
by marked upregulation of MHC-class II (Iab) and costimu-
latory B7–2 molecules, resembling our observations in hu-
man DCs (Fig. 1 A and C). The maturation of sHA-stimu-
lated DCs was accompanied by a dramatically enhanced
capacity to stimulate the proliferation of naive alloreactive T
cells in a standard MLR (Fig. 1 B and D). This phenotypic
and functional maturation exactly matched the DC matura-
tion induced by 100 ng/ml LPS (Fig. 1 D).
The Induction of TNF-  by sHA Treatment of DCs Is Time
and Dose Dependent. We have previously shown that DC
stimulated with sHA secrete large quantities of proinflam-
matory cytokines, such as IL-1 , TNF- , and IL-12, and
that sHA-induced DC maturation is TNF-  dependent
(5). To further characterize the time and dose dependence
of sHA-induced TNF-  expression, we used RT-PCR to
analyze TNF-  mRNA expression after sHA treatment of
human DCs. Rapid induction of TNF-  mRNA was ob-
served, which was detectable as early as 4 h after stimula-
tion of DCs with either 25  g/ml sHA or 100 ng/ml LPS
(Fig. 2 A). At this dose the sHA-induced TNF-  expres-
sion was more long-lasting compared with that induced by
LPS (Fig. 2 A). When the overall amount of TNF-  pro-
tein secreted into the culture medium after 24 h of stimula-
tion with different concentrations of sHA was quantified by
ELISA, there was a clear dose response in TNF-  produc-
tion, with up to 4 ng/ml being produced in response to 50
 g/ml sHA (Fig. 2 B and C). The kinetics of TNF-  in-
duction by sHA showed a late onset starting after 4–5 h of
coincubation, reaching near-peak levels after 12 h, with a
slight further increase up to 24 h. This effect was concen-
tration dependent, as 10  g/ml sHA sufficed to induce a
significant TNF-  production, while saturation was ob-
served at concentrations  20  g/ml (Fig. 2 C). In contrast,
TNF-  induction by 100 ng/ml LPS occurred much more
rapidly, with significant amounts being produced after 30
min (Fig. 2 B). We conclude that the TNF-  response is a
very sensitive parameter to measure the sHA-induced mat-
uration of DC, therefore it was adopted as the major read-
out-system in further experiments.
sHA-mediated DC Activation Requires p38-MAPK and
P42/44-MAPK Activity and Nuclear Translocation of NF-
 B. It has been shown that DC maturation by LPS in-
volves phosphorylation of p38 MAPK and p42/44 MAPK
(13). To test whether activation of the MAPK pathway
might be also involved in the sHA-induced DC matura-
tion we analyzed p38 and p42/44 MAPK in DC lysates by
Western blot analysis. After sHA treatment, but not
HMW-HA treatment, p38 and p42/44 MAPK were rap-
idly phosphorylated within 1–2 h when compared with
the total content of these MAPKs (Fig. 3 A and B). Then,
we investigated whether p42/44 MAPK activation was re-
quired for the TNF-  production leading to DC matura-
tion. DCs stimulated either with 30  g/ml sHA or 100
ng/ml LPS were preincubated for 7 h with different
concentrations of defined kinase inhibitors. Specifically,
PD98059, which blocks p42/44 MAPKs, SB-203580, a
selective inhibitor of p38-MAPKs, Herbimycin A, an in-
hibitor of src-like protein tyrosine kinases, and Wortman-
nin, a phosphatidylinositol (PI)3-kinase inhibitor were
Figure 1. sHA induces phenotypic and functional maturation of hu-
man and mouse DCs. Human monocyte–derived day 4 DCs (A and B) or
murine day 6 bone marrow–derived DCs (C and D) were used after 48-h
incubation with 20  g/ml sHA (bold line), 50  g/ml HMW-HA (solid
line), 100 ng/ml LPS (dotted line), or left untreated (broken line). (A and
C) DCs were stained with mAbs directed against MHC class II (top) or
B7–2 (CD86; lower) and analyzed by flow cytometry. A representative of
five independent experiments is shown. (B and D) The cells were coincu-
bated for 4 d with 105 alloreactive T cells at a DC:TC ratio of 1:20. T cell
proliferation was determined on day 5 by addition of 1  Ci of 3[H]thy-
midine for the final 18 h. Results are shown in counts per minute
(CPM)   SD of triplicate wells. *P   0.001 compared with untreated
DCs ( ). A representative of four independent experiments is shown.103 Termeer et al.
used as described previously (28–31). ELISA assays showed
a dose-dependent decrease in TNF-  production after
preincubation with each of the different MAPK inhibitors,
whereas Wortmannin had no effect, suggesting that p38
and p42/44 MAPKs, but not PI3-kinase are involved in
the signaling pathway induced by sHA (Fig. 3 C). Since
activation of PI3-kinase is involved in the control of intra-
cellular calcium stores, the latter finding is consistent with
our results that sHA treatment of DCs does not induce in-
tracellular calcium fluxes as analyzed by Fura labeling (data
not shown).
To determine whether the sHA-induced DC maturation
involves NF- B translocation to the nucleus, EMSA of nu-
clear extracts were performed. As shown in Fig. 4 A, sHA
induced NF- B activation in a time-dependent manner,
with a significant signal obtained as early as 30 min after
sHA treatment. Furthermore, coincubation with the spe-
cific NF- B inhibitor CAPE dose dependently inhibited
the ability of DCs to produce TNF-  and their upregula-
tion of HLA-DR (Fig. 4 B and data not shown), with an
almost total inhibitory effect observed at a concentration of
20  g/ml. As expected, NF- B liberation from the cytosol
was enhanced by LPS, with strong NF- B signaling being
observed after 30 min of incubation with LPS (Fig. 4 A).
Taken together, these data suggest that phosphorylation of
p38 and p42/44 MAPK as well as nuclear translocation of
NF- B are prerequisites for the sHA-induced TNF-  pro-
duction by DC.
TLR-4 Is Involved in the sHA-mediated TNF-  Production
by Human DCs and Is Downregulated After Stimulation.
The TLR-4 family, in particular the TLR-4 complex, has
recently been described as being involved in the LPS-
dependent activation of DCs during bacterial infection
(13). We investigated whether TLR-4 might also be in-
volved in sHA-induced activation of DCs. The anti–TLR-4
mAb HTA125 is able to block TLR-4 ligation (23).
Therefore, we analyzed what effect this antibody has on
TNF-  production by DCs in response to sHA. Preincuba-
tion of human DC for 30 min with 10  g/ml HTA125
mAb, a concentration previously shown to effectively block
TLR-4 ligation (23), was able to reduce the sHA-induced
TNF  release by these cells for up to 7 h, as found for LPS
(Fig. 5 A). A higher concentration of HTA 125 (20  g/ml)
or a longer preincubation time of 60 min could enhance the
blocking effect to some extent (Fig. 5 A). These results pro-
vide first evidence that TLR-4 is involved in the intracellu-
lar signaling and maturation of DCs induced by sHA.
To further investigate the involvement of TLRs with
sHA-induced DC maturation, we characterized the expres-
sion of TLR-4 and TLR-2 (the latter is a receptor associ-
ated with the binding of bacterial lipoproteins; reference
14) on human DCs in response to sHA treatment. RT-
PCR analysis revealed that TLR-4 as well as TLR-2
mRNA was clearly expressed in preparations of unstimu-
lated DCs. Interestingly, treatment with 20  g/ml sHA
downregulated both TLR-4 and TLR-2 mRNA expres-
sion within 6–12 h, with no signal being detectable after
12 h incubation with sHA (Fig. 5 B). Similar results were
obtained when the surface expression of TLR-4 protein on
DCs was assessed by FACS® analysis. Again, we observed
significant downregulation of the receptor after 24 h of in-
cubation with either sHA or LPS (Fig. 5 C).
From these data we conclude that TLR-4 is involved in
sHA-induced activation of DCs, and that TLR-2 and
TLR-4 are downregulated in response to sHA treatment.
To obtain more direct information about the possible in-
Figure 2. Analysis of TNF-  production by
DCs in response to sHA stimulation. (A and B)
Human monocyte–derived day 4 DCs were treated
with 25  g/ml sHA or 100 ng/ml LPS for the in-
dicated times. After stimulation, (A) cells were har-
vested and RNA was prepared for TNF- –specific
RT-PCR, and (B) cell-free supernatants were col-
lected and assayed by TNF-  ELISA. The dotted
line shows the response to LPS, the solid line the
response to sHA. Data represent the mean TNF- 
release of triplicate values; pg/mg total protein  
SD. (C) DCs were incubated for 24 h with the in-
dicated concentrations of sHA or 100 ng/ml LPS
and cell-free supernatants were collected and as-
sayed by TNF-  ELISA as detailed above.104 Oligosaccharides of Hyaluronan Activate Dendritic Cells via TLR-4
volvement of TLR-2 and TLR-4 in sHA-induced DC
maturation, we isolated DCs from the bone marrow of
TLR-2– and TLR-4–deficient mice and analyzed the ef-
fect of sHA on these cells.
DCs from TLR-4–deficient Mice Do Not Respond to sHA
Stimulation. The mouse strains C3H/HeJ and C57BL10/
ScCr are nonresponsive to LPS due to a mutation or lack of
the TLR-4 receptor, respectively (19). We used these mice
to further characterize the function of TLR-4 during sHA-
mediated DC stimulation. Bone marrow–derived DCs
from C3H/HeJ, C57BL/10ScCr, and wild-type mice were
prepared and immunophenotypically analyzed. We found
no differences in expression levels of MHC class II, costim-
ulatory molecules B7–1/B7–2 or CD11c in DCs from
TLR-4–deficient or wild-type mice (data not shown).
Moreover, the DCs from the mutant mice were function-
ally active, since they produced significant amounts of
TNF-  after coincubation with bacterial crude cell wall
extracts which were shown to activate macrophages from
TLR-4–deficient mice (17), although this amount was
lower than that produced by wild-type DCs (Fig. 6 A).
However, while sHA dose dependently stimulated TNF- 
production in wild-type DCs as expected, DCs from mu-
tant mice were completely resistant to sHA stimulation as
well as to purified LPS from S. abortus equi or S. minnesota
R595 (Fig. 6 A). We next examined whether the nonre-
sponsiveness of DCs from TLR-4 mutant mice to sHA-
stimulation is functionally relevant to their T cell stimula-
tory function. In a standard MLR, the allostimulatory
capacity of the DCs from mutant mice was significantly
Figure 3. sHA-mediated DC maturation requires
p38-MAPK and P42/44-MAPK phosphorylation. (A
and B) Human monocyte–derived day 4 DCs were
treated with 50  g/ml sHA, 100  g/ml HMW-HA,
or 100 ng/ml LPS for the times indicated. Western im-
munoblotting was performed using mAbs specific for
the phosphorylated kinase (top) or total kinase content
of the cells (bottom). Shown are blots for (A) p38
MAPK and (B) p42/44 MAPK. (C) Supernatants of
DCs stimulated with 30  g/ml sHA or 1 ng/ml LPS in
the presence of the indicated concentrations of the
MAPK inhibitors PD98059 (p38), SB 203580 (p42/44),
Herbimycin A (src-like tyrosine kinases), or Wortman-
nin (PI3-kinase) were harvested after 7 h and screened
for their TNF-  content by ELISA. Data represent the
mean TNF-  release of triplicate wells; pg/mg total
protein   SD.105 Termeer et al.
lowered on sHA treatment when compared with wild-type
DCs (Fig. 6 B). In comparison, HMW-HA had no effect
on either the TNF-  release or the T cell stimulatory ca-
pacity of both wild-type and mutant DCs, even at concen-
trations of 100  g/ml (Fig. 6). Since TLR-4 is the major
receptor for LPS and concentrations as low as 50 pg/ml
have been described to activate cells of the myelomono-
cytic lineage (32), we wished to exclude the possibility of
endotoxin contamination in the sHA preparations used in
this study. LAL assays showed a maximum endotoxin con-
tent of 0.1 ng/ml in our 1 mg/ml sHA stock solutions, re-
sulting in a maximum possible contamination throughout
the assays of 0.005 ng/ml in the 50  g/ml concentration of
sHA. Titration experiments with purified LPS from S. abor-
tus equi were performed, showing that DCs under the cul-
ture conditions used in our experiments did not respond to
LPS concentrations  0.2 ng/ml (data not shown). Further-
more, blocking experiments were performed by preincu-
bating the DCs with 10  g/ml of the LPS-inhibitor poly-
myxin B before sHA stimulation (Fig. 6 C). Polymyxin B
had no effect on the sHA-induced upregulation of IAb,
B7–1, or B7–2, but in the same experiment inhibited the
LPS effect almost completely (Fig. 6 C).
sHA-mediated DC Stimulation Is Not Dependent on TLR-2
Expression. TLR-2 is a receptor that has been associated
with macrophage activation by membrane lipoproteins/
lipopeptides from Borrelia burgdorferi, Treponema pallidum,
and Mycoplasma fermentans (14, 33). To examine whether
TLR-2 plays a role in sHA-induced DC maturation, DCs
from TLR-2–deficient (14) and wild-type mice were gen-
erated from bone marrow. These cells were treated with
either LPS or sHA and their ability to secrete TNF-  in
response to these substances was compared. TLR-2–defi-
cient DCs responded well to LPS and sHA (Fig. 7 A).
These data were confirmed at the functional level, since in
a standard MLR, the allostimulatory capacity of the DCs
from mutant mice was significantly enhanced upon sHA
and LPS treatment (Fig. 7 B). Taken together, these data
suggest that sHA-mediated DC stimulation is dependent
on TLR-4 but not on TLR-2, since the presence of a
nonfunctional mutated TLR-4 receptor in DCs could not
support sHA-induced DC maturation, while TLR-2–
Figure 4. The sHA-induced DC maturation is NF- B
dependent. (A) Nuclear extracts were prepared from DCs
treated with either HMW-HA (30  g/ml), sHA (30  g/
ml), LPS (10 ng/ml), or left untreated. A total of 10  g of
protein from each nuclear extract was analyzed for NF- B
activity by EMSA. The arrow indicates specific NF- B
bands. (B) Supernatants of DCs stimulated with 30  g/ml
sHA (white bars) or 10 ng/ml LPS (black bars) in the pres-
ence of the indicated concentrations of the NF- B inhibi-
tor CAPE were harvested after 7 h and screened for their
TNF-  content by ELISA. Data represent the mean TNF- 
release of triplicate wells; pg/mg total protein   SD.106 Oligosaccharides of Hyaluronan Activate Dendritic Cells via TLR-4
deficient DCs responded to sHA in a similar manner to
wild-type DCs.
In Vivo Relevance of the sHA-induced DC Activation.
The data presented so far suggesting that sHA-induced DC
maturation is dependent on TLR-4 were produced using
in vitro methods. Therefore, we set out to determine the
in vivo relevance of sHA-induced DC maturation. In a
first attempt, full thickness skin organ cultures were floated
on medium containing 30  g/ml sHA or 100 ng/ml LPS
(Fig. 8 A). After 24 h, cells that had migrated into the cul-
ture medium were collected and double stained for CD11c
and IaB expression. FACS® analysis of high forward scatter,
highly CD11c/IaB-positive cells showed that a significant
higher percentage of DCs appeared in the culture medium
when sHA was added (Fig. 8 A). In contrast, ear skin from
TLR-4–deficient mice did not show an enhanced DC em-
igration in response to sHA or LPS (Fig. 8 A). In a second
set of experiments, 100  g/animal sHA or 10  g LPS
were injected intravenously into C57BL/10ScCr and
wild-type mice (Fig. 8 B). The mice were killed after 12 h
and forward scatter high, highly CD11c-expressing cells
were quantified in spleen cell suspensions for their IaB/B7–2
expression (Fig. 8 B). sHA induced an significant enrich-
ment of highly Iab and B7–2 positive, activated DCs (Fig.
8 B). In contrast, injection of sHA into TLR-4–deficient
mice did not result in an upregulation of Iab and B7–2 on
splenic DCs (Fig. 8 B). To quantify their functional activ-
ity, DCs were purified from spleens and tested for their al-
lostimulatory function using naive T cells from BALB/c
mice as responders (Fig. 8 B). Thymidine incorporation
clearly demonstrated an enhanced T cell proliferation in-
duced by DCs isolated from spleens of wild-type mice that
were injected with sHA compared with PBS treated con-
trols. In contrast, DCs isolated from TLR-4–deficient
C57BL/10ScCr injected with sHA did not induce an en-
hanced T cell proliferation (Fig. 8 B). From these results
we conclude that exogenously applied sHA is able to in-
duce DC activation in vivo and this activation is again me-
diated by TLR-4–dependent mechanisms.
Discussion
The activation of DCs plays a critical role in the devel-
opment of T cell–mediated immune responses. Our previ-
ous work has made it clear that low-molecular weight deg-
radation products of HA (sHA) produced at sites of
inflammation are key players in DC activation (5). The ex-
citing outcome of the study presented here is that the mat-
uration and activation of human and murine DCs in
response to sHA is dependent on a functional TLR-4
receptor complex. Thus, sHA was able to mediate activa-
tion of bone marrow–derived DCs from wild-type C3H/
Figure 5. TLR-4 mediates
TNF-  production of sHA-
stimulated human DCs and is
downregulated after activation.
(A) Anti–TLR-4 antibodies in-
hibit TNF-  production by DCs
in response to sHA (left) and LPS
(right). DCs were either prein-
cubated for 30 or 60 min with
10 or 20  g/ml of the anti–
TLR-4 mAb HTA 125 as indi-
cated, a matched IgG-isotype
control (black circles) or left un-
treated (white circles). The cells
were then stimulated with 30
 g/ml sHA (left) or 100 ng/ml
LPS (right) for the times (h) indi-
cated. Supernatants were har-
vested and screened for their
TNF-  content by ELISA as de-
scribed previously. Data repre-
sent the mean TNF-  release of
triplicate wells; ng/mg total pro-
tein. (B) Total mRNA from hu-
man DCs treated either with 100
ng/ml LPS or 30  g/ml sHA for
the indicated times was analyzed
by RT-PCR. The top shows
TLR-2, the middle TLR-4 reg-
ulation, the bottom shows
 -actin control. (C) DCs were
analyzed by FACS® for their sur-
face-expression of TLR-4 on:
untreated control DCs (solid
line), HMW-HA–treated DCs (30  g/ml; dashed line), sHA-treated DCs (30  g/ml; bold line), and LPS-treated DC (1 ng/ml; dotted line). Dot-dash
line: DCs stained with secondary antibody alone. A representative of three independent experiments is shown.107 Termeer et al.
HeN and C57BL/10Sn mice but not of DCs from the re-
spective closely related C3H/HeJ and C57BL/10ScCr
mice, which on account of defects in TLR-4 are LPS
nonresponder and exhibit no inflammatory response to
endotoxin. In contrast, DCs from TLR-2–deficient mice
retained the ability to respond to sHA. Furthermore,
blockade of TLR-4 on human monocyte–derived DCs
abrogated their ability to produce TNF-  in response to
sHA. The stimulatory effects of sHA on DCs were medi-
ated by components of the signaling pathway activated by
TLR-4, including the phosphorylation of p38 and p42/
p44 MAPK and the translocation of NF- B to the nu-
cleus.
It is becoming increasingly evident that subcomponents
of the extracellular matrix, especially of those built of re-
peating disaccharide units, can have immunomodulatory
functions. NF- B and intracellular adhesion molecule 1 are
induced in endothelial cells by dermatan sulfate, a substance
with high structural homology to HA (34), and low molec-
ular weight heparan sulfate can modulate the migration of
epidermal Langerhans cells, the immature precursors of
skin DCs (35). Nevertheless, it remains unclear whether
these low molecular weight fragmentation products use the
same or different receptors to exert their effects compared
with the intact parental macromolecule. HMW-HA binds
to CD44 and RHAMM (36), but we and others could ex-
Figure 6. DCs derived from TLR-4–
deficient mice are not sensitive to sHA
stimulation. (A) Bone marrow–derived DCs
were obtained from either C3H/HeN
(wild-type) and C3H/HeJ (TLR-4 mutant)
or C57BL/10ScSn (wild-type) and C57BL/
10ScCr (TLR-4 mutant). On day 6 of cul-
ture the DCs were either incubated with
100 ng/ml of bacterial cell wall lysates con-
taining LPS and other substances such as li-
poprotein, or 100 ng/ml highly purified
LPS from Salmonella abortus equi or Salmo-
nella minessota strain R595 as positive and
negative controls. Alternatively, 10 or 50
 g/ml sHA or 100  g/ml HMW-HA were
added. After 48 h of treatment the cell free
supernatants were screened for their TNF- 
content by ELISA. Data represent the mean
TNF-  release of triplicate wells; pg/mg to-
tal protein   SD. (B) DCs were treated for
48 h with the same substances described in
A, washed, and coincubated for 4 d with
105 alloreactive T cells at a DC/TC ratio of
1:20. T cell proliferation was determined on
day 5 by addition of 1  Ci of 3[H]thymi-
dine for the final 18 h. Results are shown in
counts per minute (CPM)   SD of tripli-
cate wells. (C) Day 6 bone marrow–derived
DCs of either C57BL/10Sn (black bars) or
C57BL/10Cr (white bars) were incubated
for 24 h with 30  g/ml sHA or 100 ng/ml
LPS and/or pretreated with 10 mg/ml poly-
myxin B (polyB) 1 h before stimulation. Af-
ter 24 h of incubation DCs were stained for
Iab, B7–1, and B7–2 expression and ana-
lyzed by flow cytometry. Results are shown
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clude binding of sHA fragments to these receptors (5, 37).
Here we show for the first time that small fragmentation
products of HA use receptors and signaling cascades which
are different from those used by HMW-HA.
The concentrations of sHA needed to induce TLR-4–
mediated signaling in DCs are several orders of magnitude
higher than for LPS. This makes sense, as HA is a physio-
logical constituent of the organism and minute amounts of
degradation products enter into the bloodstream to be fur-
ther degraded in the liver. Interestingly, higher levels of
circulating HA are found during sepsis, correlating with
disease severity and prognosis (38). For these reasons, it
seems most plausible that only high concentrations of sHA,
occurring locally and exclusively at sites of inflammation,
induce proinflammatory signals. Our preliminary data using
suction blister fluid (24) suggest that small glycosaminogly-
can fragments of 4–6 oligosaccharides in size are indeed
produced locally in inflamed skin (data not shown), consis-
tent with this hypothesis.
There are many similarities between activation of DCs
by LPS and by sHA. For example, DCs from TLR-4–defi-
cient mice are nonresponsive to both LPS and sHA, but
TLR-2–deficient DCs are still activated by both substances.
Therefore, we performed extensive controls to exclude the
possibility that our sHA preparations were contaminated
with LPS. In this regard, it is also significant that while
there are similarities between the signaling pathways in-
duced by LPS and sHA, a critical difference is that LPS in-
duces PI3-kinase (39), whereas we show here that sHA
does not. Moreover, ligation of the TLR-4 complex by
LPS in mouse macrophages occurs very rapidly, with the
receptor being downregulated within 1 h after stimulation
(40). In contrast, we found that both the intracellular sig-
naling and TNF-  protein synthesis by sHA-stimulated
DCs are notably delayed for  5–6 h in comparison to LPS.
Thus, although we cannot completely rule out the possibil-
ity that sHA might act synergistically with trace amounts of
LPS present in our sHA preparations which are below the
threshold of detection and which alone cannot mediate DC
maturation, a much more likely interpretation of our re-
sults is that sHA is an independent inducer of DC activa-
tion which signals via TLR-4.
It remains to be shown how sHA induces TLR-4 signal-
ing at the molecular level. Recent results demonstrate that
TLR signaling is dependent on a complex series of protein
interactions, which is well exemplified by LPS signaling via
TLR-4 (13, 18). In addition to TLR-4, the serum protein
LBP and the GPI-linked cell surface protein CD14 are re-
quired for the host response to LPS (16). LPS binds to LBP,
which in turn binds to CD14. The LPS-LBP-CD14 com-
plex is then thought to interact with TLR-4, perhaps di-
rectly (15, 41), which in turn induces TLR-4 signaling via
MyD88 and IRAK. TLR-4 also appears to contact LPS di-
rectly within the multiprotein complex. A further protein
called MD-2 is also required for LPS-induced signaling (23,
41). This secreted extracellular protein binds to the extra-
Figure 7. sHA-mediated DC stimulation is not de-
pendent on TLR-2 expression. Day 6 bone marrow–
derived DCs from C57BL/6 or C57BL/6TLR-2 / 
were incubated for 48 h with the indicated concentra-
tions of highly purified LPS from Salmonella abortus equi
or sHA. (A) The cell free supernatants were screened
for their TNF-  content by ELISA. Data represent the
mean TNF-  release of triplicate wells; pg/mg total
protein   SD. (B) DCs were treated for 48 h with the
same substances described in A, washed, and coincu-
bated for 4 d with 105 alloreactive T cells at a DC/TC
ratio of 1:20. T cell proliferation was determined on
day 5 by addition of 1  Ci of 3[H]thymidine for the fi-
nal 18 h. Results are shown in counts per minute
(CPM)   SD of triplicate wells.109 Termeer et al.
cellular portion of TLR-4 and possibly stabilizes TLR-4
dimers (23, 42). The complex molecular interactions in-
volved in TLR signaling appears define the range of sub-
stances to which a given TLR can recognize, with the
specificity determined at least in part by the TLR accessory
molecules which bind to the ligand (42).
In sHA-induced TLR-4 signaling, sHA might bind to
known TLR-4 accessory molecules, but more likely to as-
yet unidentified ones. This latter possibility is underscored
by structural considerations: LPS and sHA share almost no
homology, except for the highly diverse repeating sugar
units at the end of the LPS molecule (43). However, the
binding of LPS to the TLR-4 complex and its activat-
ing effect on macrophages is mediated by the Lipid A moi-
ety of the molecule (43). Furthermore, other substances
known to bind the TLR-4 complex show high diversity.
Human heat shock protein 60 can induce a TLR-4 com-
plex–dependent activation of macrophages by upregulation
of adhesion molecules and the release of proinflammatory
mediators (20). Taxol, a dipertene purified from the bark of
Taxus brevifolia, also mediates a TLR-4– and MD-2–
dependent activation of murine macrophages. Interestingly
this effect could only be observed with murine cells, but
not with human LPS responsive cells (21). Therefore, it is
significant that we found sHA to effectively activate both
murine and human DCs which is suggestive of a highly
conserved mechanism, since human TLR-4 has been de-
scribed as being more effective in the discrimination of
possible ligands (21, 44). Future work will focus on dissect-
ing the way in which sHA interacts with components of
the TLR-4 complex to induce the signal transduction
which leads to DC maturation.
It is clear from the data presented here and from our pre-
vious studies (5) that the sHA-induced DC activation is de-
pendent on the induction of TNF-  secretion. Our data
suggest that TLR-4 is required for this induction, as TLR-
4–deficient DCs did not produce TNF-  in response to
sHA, and an anti–TLR-4 antibody was able to block sHA-
Figure 8. In vivo relevance of the sHA-induced DC
stimulation. (A) Full thickness skin was obtained from
the outer epidermal sheet of the ears of C57BL/10ScSn
wild-type (TLR / ) and TLR-4 /   C57BL/10Cr
mice at three animals per group. Ear sheets were
floated on supplemented RPMI 1640 with or without
addition of 30  g/ml sHA or 100 ng/ml LPS. After
24 h, cells that had migrated into the culture medium
were collected and double stained for CD11c and IaB
expression. Large, highly CD11c and IaB-positive cells
were considered as DCs and the percentage was calcu-
lated by flow cytometry. A representative of two inde-
pendent experiments is shown. (B) 100  g/animal
sHA or 100  l PBS was injected intravenous into the
tail vein of C57BL/10ScSn wild-type (TLR / ) and
TLR-4   /  C57BL/10Cr mice at three animals per
group. The mice were killed after 12 h and large,
highly CD11c-positive cells in the spleens were ana-
lyzed for their IaB and B7–2 expression by flow cytome-
try. Results are shown as mean fluorescence intensities
(MFI) in the marked gates   SD. Further, DCs were
isolated from spleen cells and 5   103 DCs were restim-
ulated for 4 d with 105 allogenic T cells from BALB/c
mice. T cell proliferation was determined on day 4 by
addition of 1  Ci of 3[H]thymidine for the final 18 h.
Results are shown as counts per minute (CPM)   SD
of triplicate wells. A representative of two independent
experiments is shown.110 Oligosaccharides of Hyaluronan Activate Dendritic Cells via TLR-4
mediated TNF-  release by wild-type DCs. However, the
anti–TLR-4 antibody had no effect on TNF-  production
if given 7 h after sHA treatment (Fig. 5 A). This coincides
with downregulation of TLR-4 expression in response to
sHA, although there is clearly some TLR-4 on the surface
of DCs 24 h after sHA treatment (Fig. 5 B and C). These
data are consistent with the notion that TNF-  produced
by DCs in response to sHA binds to the TNF receptor I on
the same cells, which in turn delivers a signal that produces
more TNF-  (45).
The current understanding of TLRs and their associated
molecules suggests that these multi-protein complexes de-
veloped in lower organisms such as Drosophila to provide
innate immunity by recognizing conserved motifs present
on pathogens. Therefore, it is fascinating that the data pre-
sented here suggest that the same molecular machinery in-
volved in the innate immune response has perhaps been
evolutionarily coopted to activate the immune response in
response to degradation of endogenous extracellular matrix
components during inflammation. Further study of the
TLRs and the molecules they interact with will undoubt-
edly reveal many more new and exciting insights into the
molecular mechanisms which regulate immunity.
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